Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John P. Schmid currently holds 30,000 shares of Auspex Pharmaceuticals, Inc. (ASPX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Schmid has been a net buyer of ASPX stock. They have purchased $149.9K and sold $85.0K worth of shares.
John P. Schmid's most recent insider trade was on Dec 23, 2025, when they sold 11,068 shares at $51.00 per share.
John P. Schmid serves as Executive at Auspex Pharmaceuticals, Inc. (ASPX). They have executed 50 insider transactions totaling $234.9K over their tenure at the company.
John P. Schmid holds the position of Executive at Auspex Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
John P. Schmid has shown a buying trading pattern, with $149.9K in total purchases and $85.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John P. Schmid was on Dec 23, 2025, when they sold $564.5K worth of ANAB shares. This transaction involved 11,068 shares at $51.00 per share.
John P. Schmid currently owns 30,000 shares of Auspex Pharmaceuticals, Inc. (ASPX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John P. Schmid's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John P. Schmid has 50 Form 4 filings on record as an insider at Auspex Pharmaceuticals, Inc..
Set alerts for John P. Schmid and 40,000+ other insiders.